Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients and at point-of-care testing by healthcare professionals.
Lateral flow (LF) devices and tests have been a popular platform for rapid immunoassays since their introduction in the mid-1980s, and since our last look at the market there has been continued interest and innovations. This report profiles over a hundred companies that currently market lateral flow tests. Many of these companies, plus more than ten additional companies, are developing innovations in lateral flow-based devices. Companies profiled in this report use lateral flow technology to develop and market a wide range of rapid tests for market segments of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
Every critical aspect of the lateral flow test market is addressed, including the following key topics:
This report provides a realistic assessment acknowledging the reality of payors’ emphasis on cost/benefit analysis for new technologies. Current sales and predictions for 2017 sales are provided for the diabetes, oncology, cardiac marker, pregnancy and other LF test markets.
Kalorama’s unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.
For the purpose of this study, Kalorama Information conducted telephone and email interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with device company representatives included marketing directors, division managers, and product development representatives.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2012 to 2017.
Related Reports:The Market and Potential for Molecular Point of Care Diagnostics
Feb 26, 2016 - KLI5916011 - $4,200.00
POC Cholesterol Testing Market
Jan 26, 2016 - KLI5856829 - $995.00
World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)
Jan 22, 2016 - KLI5757702 - $3,995.00
IVD in India
Jan 6, 2016 - KLI5819260 - $4,200.00
POC Pregnancy and Fertility Testing Market
Dec 29, 2015 - KLI5814231 - $995.00
POC Urinalysis Testing Market
Dec 17, 2015 - KLI5793648 - $995.00
The World Market for Infectious Disease Diagnostic Tests
Nov 1, 2015 - KLI5721838 - $4,500.00
Mergers and Acquisitions in the IVD Market
Oct 26, 2015 - KLI5722029 - $750.00
IVD in China
Jun 11, 2015 - KLI5586455 - $3,500.00
The World Market for Point of Care (POC) Diagnostics
Jun 2, 2015 - KLI5573392 - $4,200.00
Questions?Contact a research specialist >
Live Chat Software
Most Popular ResearchThe Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition The 2015 IVD Market: Year in Review Top IVD Market Trends to Watch in 2016 Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) IVD Procedure Volumes and Pricing Analysis